Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Niger J Clin Pract ; 22(1): 92-100, 2019 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-30666026

RESUMEN

OBJECTIVES: A prospective case-control study was carried out to assess the value of elastosonography in identifying endometrial pathology in women using Tamoxifen (TAM) for breast cancer. MATERIALS AND METHODS: In total, 66 women using TAM for breast cancer were enrolled for the study with 61 premenopausal and 61 postmenopausal healthy controls. Ultrasonographic findings (strain ratio, endometrial thickness) were evaluated in regard to the duration of TAM usage, histopathological findings, and menopausal status. RESULTS: Patients with endometrial cancer (EC) and cystic endometrial hyperplasia (CEH) were found to have longer duration of TAM usage, increased endometrial thickness, and higher strain ratios compared with controls. A significant positive correlation was found between duration of TAM usage, endometrial thickness, and the strain ratios. Endometrial thickness and the strain ratios were significant predictors for groups under risk. Cutoff values for endometrial thickness, strain ratios, and duration of TAM usage were 12.55 mm, 2.46, and 18 months in premenopausal group and 7.75 mm, 7.70, and 32 months in postmenopausal group to predict risky population, respectively. CONCLUSION: Endometrial tissue strain ratio was found to be significantly increased in cases with endometrial pathologies. Addition of elastosonography modality to B-mode may improve the diagnostic accuracy during the follow-up of women using TAM for breast cancer.


Asunto(s)
Antineoplásicos Hormonales/efectos adversos , Neoplasias de la Mama/tratamiento farmacológico , Diagnóstico por Imagen de Elasticidad/métodos , Hiperplasia Endometrial/diagnóstico por imagen , Neoplasias Endometriales/diagnóstico por imagen , Endometrio/diagnóstico por imagen , Tamoxifeno/efectos adversos , Ultrasonografía/métodos , Adulto , Anciano , Anciano de 80 o más Años , Antineoplásicos Hormonales/uso terapéutico , Neoplasias de la Mama/patología , Estudios de Casos y Controles , Hiperplasia Endometrial/inducido químicamente , Neoplasias Endometriales/inducido químicamente , Endometrio/efectos de los fármacos , Femenino , Humanos , Persona de Mediana Edad , Posmenopausia , Premenopausia , Estudios Prospectivos , Tamoxifeno/uso terapéutico
2.
J Obstet Gynaecol ; 35(7): 696-8, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25692404

RESUMEN

The aim of this study was to evaluate the relationship between placental localisation and perinatal outcomes. This study was performed in a tertiary centre hospital by retrospectively analysing the medical records of patients who were followed up and underwent delivery in the same hospital. The patients were divided into two groups according to the placental locations (central and lateral) in their routine sonographic findings between the 18 and 24 weeks' gestation. Out of 1,057 patients, 87.4% (n = 919) had centrally located placentas and 12.6% (n = 133) had laterally located placentas. Preeclampsia was found to be significantly higher in the lateral placental location group (4.5% vs. 1.6%; p = 0.027). There was a significant correlation with foetal growth restriction (FGR), preterm birth rates, low Apgar scores and need for neonatal intensive care unit in the lateral placental location group (p < 0.05). The pregnant women with laterally located placentas should be followed up promptly with special care for the risk of preeclampsia and FGR, and poor neonatal outcomes.


Asunto(s)
Retardo del Crecimiento Fetal/epidemiología , Placenta/diagnóstico por imagen , Preeclampsia/epidemiología , Nacimiento Prematuro/epidemiología , Adulto , Puntaje de Apgar , Femenino , Humanos , Incidencia , Cuidado Intensivo Neonatal , Oligohidramnios/epidemiología , Placenta/patología , Embarazo , Estudios Retrospectivos , Ultrasonografía Prenatal , Adulto Joven
3.
Ultrason Sonochem ; 13(3): 208-14, 2006 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-15935721

RESUMEN

Lab-scale degradation of azo dyes with ultrasound (300 kHz), ozone and both was investigated using an aryl-azo-naphthol dye-C.I. Acid Orange 8. It was found that in all schemes color decay was faster than UV absorbance, and the rates followed pseudo-first-order kinetics except for the decay of UV-254 band by ozone. Sonication alone was sufficient for decolorization, but not for UV absorption abatement or mineralization. Ozonation was more effective than ultrasound in bleaching, but not as much for the mineralization of the dye. Combined operation of ultrasound and ozone improved the rate of bleaching and UV absorption decay and remarkably enhanced the mineralization of the dye. This was attributed to increased mass transfer of ozone in solution and its decomposition in the gas phase to yield hydroxyl radicals and other oxidative species. The effect of alpha-methyl substituent at the aryl carbon of the dye was found to decelerate the rate of degradation as a result of weakened intramolecular hydrogen bonding.


Asunto(s)
Colorantes/análisis , Ozono/química , Ultrasonido , Contaminantes Químicos del Agua/análisis , Purificación del Agua/métodos , Compuestos Azo/análisis , Compuestos Azo/química , Colorantes/química , Isomerismo , Estructura Molecular , Naftoles/análisis , Naftoles/química , Oxidación-Reducción , Purificación del Agua/instrumentación
4.
Eur J Obstet Gynecol Reprod Biol ; 198: 105-109, 2016 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-26803388

RESUMEN

OBJECTIVE: To evaluate if elastosonography of the endometrium can differ between normal endometrial tissue and abnormal pathology. STUDY DESIGN: One hundred and six women with a sonographic finding of thickened endometrium were enrolled in this study. All patients underwent B-mode scanning and elastosonography, performed by the same operator who was blinded to the study design. After sonographic evaluation, all patients underwent endometrial tissue sampling via dilatation and curettage. Histopathological results indicated that 22 patients had endometrial hyperplasia, 20 patients had endometrial polyps, and 64 patients had normal pathology results, with or without abnormal uterine bleeding. Groups were formed according to histopathological results, and ultrasonographic findings (strain ratio, endometrial thickness) were compared. RESULTS: Median age was 46 [interquartile range (IQR) 4] years, 37 (IQR 10) years and 36 (IQR 10) years for the endometrial hyperplasia, endometrial polyps and normal pathology groups, respectively. Median age of the endometrial hyperplasia group was significantly higher compared with the endometrial polyps and normal pathology groups (p<0.001). Median parity was 3 (IQR 2), 2 (IQR 1) and 3 (IQR 1) for the endometrial hyperplasia, endometrial polyps and normal pathology groups, respectively; differences between the groups were not significant (p=0.102). No differences were found between the groups in terms of endometrial thickness (p>0.05). When elastosonographic strain (B/A) ratios were compared between the groups, the endometrial hyperplasia and endometrial polyps groups had significantly lower B/A ratios (higher elasticity) than the normal pathology group (p<0.001). There was no significant difference in B/A ratios between the endometrial hyperplasia and endometrial polyps groups (p>0.05). CONCLUSION: The elasticity of endometrial tissue, measured non-invasively via elastosonography, was similar in women with endometrial polyps and endometrial hyperplasia, but differed significantly compared with women with normal pathology who had a sonographic finding of thickened endometrium and abnormal bleeding as the presenting complaint. According to these results, elastosonography cannot be used as a diagnostic tool to differentiate between endometrial hyperplasia and endometrial polyps. However, elastosonography can be used to differentiate between pathological endometrial changes and normal endometrium in patients presenting with a sonographic finding of thickened endometrium.


Asunto(s)
Diagnóstico por Imagen de Elasticidad/métodos , Hiperplasia Endometrial/diagnóstico por imagen , Neoplasias Endometriales/diagnóstico por imagen , Endometrio/diagnóstico por imagen , Pólipos/diagnóstico por imagen , Ultrasonografía/métodos , Adulto , Diagnóstico Diferencial , Femenino , Humanos , Persona de Mediana Edad
5.
Inflammopharmacology ; 6(1): 53-65, 1998.
Artículo en Inglés | MEDLINE | ID: mdl-17638127

RESUMEN

The involvement of opiatergic mechanisms on the antiamnestic effects of piracetam was investigated in mice. First, the effects of piracetam and naloxone on the amnesia induced by scopolamine, electroconvulsive shock and morphine were evaluated by using elevated plus maze apparatus. Second, the effects of electroconvulsive shock and piracetam on the antinociceptive action of morphine were tested by means of radiant heat tail-flick experiment. Piracetam and naloxone reversed the drug- or electrically-induced amnestic effects. On the other hand, electroconvulsive shock treatment enhanced the antinociceptive effect of morphine while piracetam decreased the same activity. These results suggest an important role of the opiatergic system on the learning and memory process as well as on the antiamnestic effect of piracetam.

6.
Pharmacology ; 53(2): 71-8, 1996 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-8902871

RESUMEN

The antinociceptive effect of dipyrone, a nonsteroidal and inflammatory drug, was studied in a series of experiment employing tail-flick and hot-place models and the abdominal constrictor test. The drug was given via intracerebroventricular (i.c.v.), intrathecal (i.t.) or subcutaneous (s.c.) routes. Dipyrone exhibited no analgesic activity in the tail-flick and hotplate tests while it inhibited the number of stretches in a dose-dependent manner. The antinociceptive effect of dipyrone administered by the i.c.v. and i.t. routes was almost complete reversed by naloxone treatment. The same procedure attenuated but not completely inhibited the dipyrone action induced by s.c. administration. Histopathological examination revealed that i.t. dipyrone application produces no significant lesion in the spinal cord. The results suggest that dipyrone may exert a central antinociceptive action reversed by naloxone.


Asunto(s)
Analgésicos/farmacología , Antiinflamatorios no Esteroideos/farmacología , Dipirona/farmacología , Analgésicos/administración & dosificación , Animales , Antiinflamatorios no Esteroideos/administración & dosificación , Dipirona/administración & dosificación , Relación Dosis-Respuesta a Droga , Femenino , Inyecciones Intraventriculares , Inyecciones Espinales , Inyecciones Subcutáneas , Masculino , Ratones , Naloxona/administración & dosificación , Naloxona/farmacología , Antagonistas de Narcóticos/administración & dosificación , Antagonistas de Narcóticos/farmacología , Dolor/tratamiento farmacológico , Traumatismos de la Médula Espinal/inducido químicamente
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA